Tuesday, September 15, 2009

Wykanta Acquires Asian Distribution Rights for Global Biotech Corp.’s (GBIQ.OB) Products

Global Biotech Corp., a publicly traded green consumer health products development company, recently announced that Wykanta International, Inc., an international nutraceuticals company, is acquiring the exclusive Asian distribution rights for all of Global Biotech’s product line. This agreement includes Global Biotech’s leading oxygenated product “Aquaboost™,” a water product well-positioned to become a leader in the fast-growing oxygenated water consumer market.

Under the terms of the agreement, Wykanta International, Inc. will have the exclusive distribution rights for all Global Biotech’s new and existing products in the Asian market, including China, Japan, Korea, Thailand, Indonesia and India. The agreement applies to all of GBC’s existing product line as well as any new products that may be introduced in the future. This agreement provides Wykanta with an expanded customer base that it will sell to, in addition to its Adnutrio weight loss line of products.

In addition to the retail sales of the company’s weight loss products through its wholly owned subsidiary Adnutrio International Inc., the management team at Wykanta International, Inc. believes that this exclusive agreement with Global Biotech will provide the company with an expanded consumer base and will help support the company’s future growth prospects internationally.

About QualityStocks:

QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.

Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

The Quality Stocks Daily Stock Report http://video.qualitystocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No comments:

Post a Comment